BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 14552432)

  • 1. Plasma cell myeloma marrow diagnosis including morphologic and phenotypic features.
    Grogan TM
    Semin Diagn Pathol; 2003 Aug; 20(3):211-25. PubMed ID: 14552432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haematologists usually over-estimate the percentage of CD138+ plasma cells in marrow biopsies.
    Chai KY; Boyke Berahmana AA; Morison IM
    Pathology; 2019 Oct; 51(6):647-648. PubMed ID: 31470997
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of multiparameter flow cytometry and bone marrow trephine immunohistochemistry in the identification and characterization of neoplastic plasma cells.
    Menter T; Abdulsalam AH; Nadal-Melsio E; Yebra-Fernandez E; Flora RS; Ahmad R; Rahemtulla A; Naresh KN
    Br J Haematol; 2017 Nov; 179(3):499-501. PubMed ID: 27378518
    [No Abstract]   [Full Text] [Related]  

  • 4. CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma.
    Olteanu H; Harrington AM; Kroft SH
    Am J Clin Pathol; 2012 Dec; 138(6):867-76. PubMed ID: 23161721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
    Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow trephine biopsy findings in myeloma with small-lymphoid cells and CCND1 translocation.
    Abdalla S; May PC; Garimberti E; Naresh KN
    Am J Hematol; 2011 Dec; 86(12):1038. PubMed ID: 21898528
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracellular and extracellular rhomboid shaped crystalline inclusions in a case of IgG lambda restricted plasma cell myeloma: a case report and review of the literature.
    Matoso A; Rizack T; Treaba DO
    Diagn Pathol; 2010 Jan; 5():6. PubMed ID: 20205792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological diagnosis of plasmocytic myeloma in trephine biopsy (histological and immunohistochemical criteria)].
    Baĭkov VV
    Arkh Patol; 2007; 69(2):50-2. PubMed ID: 17642196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma.
    Giannakoulas N; Ntanasis-Stathopoulos I; Terpos E
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC1 (EMA) expressing plasma cells in bone marrow infiltrated by plasma cell myeloma.
    Baldus SE; Palmen C; Thiele J
    Histol Histopathol; 2007 Aug; 22(8):889-93. PubMed ID: 17503346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells.
    Katodritou E; Terpos E; North J; Kottaridis P; Verrou E; Gastari V; Chadjiaggelidou C; Sivakumaran S; Jide-Banwo S; Tsirogianni M; Kapetanos D; Zervas K; Lowdell MW
    Am J Hematol; 2011 Dec; 86(12):967-73. PubMed ID: 21919039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bone marrow sections, smears and immunohistological staining for immunoglobulin light chains in the diagnosis of benign and malignant plasma cell proliferations.
    Thiry A; Delvenne P; Fontaine MA; Boniver J
    Histopathology; 1993 May; 22(5):423-8. PubMed ID: 7688339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.
    Matsue K; Matsue Y; Kumata K; Usui Y; Suehara Y; Fukumoto K; Fujisawa M; Narita K; Takeuchi M
    Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.
    Noll JE; Williams SA; Tong CM; Wang H; Quach JM; Purton LE; Pilkington K; To LB; Evdokiou A; Gronthos S; Zannettino AC
    Haematologica; 2014 Jan; 99(1):163-71. PubMed ID: 23935020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated digital enumeration of plasma cells in bone marrow trephine biopsies of multiple myeloma.
    Malherbe JAJ; Fuller KA; Mirzai B; Augustson BM; Erber WN
    J Clin Pathol; 2022 Jan; 75(1):50-57. PubMed ID: 33234694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncoprotein phenotype of plasma cells from patients with multiple myeloma.
    Brown RD; Pope B; Luo XF; Gibson J; Joshua D
    Leuk Lymphoma; 1994 Dec; 16(1-2):147-56. PubMed ID: 7696921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma.
    Gonsalves WI; Timm MM; Rajkumar SV; Morice WG; Dispenzieri A; Buadi FK; Lacy MQ; Dingli D; Leung N; Kapoor P; Kyle RA; Gertz MA; Kumar SK
    Leuk Res; 2016 May; 44():32-9. PubMed ID: 26994849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spindle cell lesion in the bone marrow.
    Guzman S; Kitahara S
    Blood; 2018 Sep; 132(10):1085. PubMed ID: 30190353
    [No Abstract]   [Full Text] [Related]  

  • 19. IgD plasmablastic myeloma: a case report with emphasis on the cytological features.
    Ishida M; Hodohara K; Okuno H; Yoshii M; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2014; 7(3):1250-4. PubMed ID: 24696745
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoplasms of terminally differentiated B lymphocytes.
    Holbert JM
    Clin Lab Med; 1988 Mar; 8(1):197-210. PubMed ID: 3282759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.